Erasca to Present at Upcoming Investor Conferences

GlobeNewswire11-05

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences and will also participate in one-on-one investor meetings.

Guggenheim Securities Healthcare Innovation Conference (November 11 – 13, 2024)
Location: InterContinental Hotel, Boston, MA
Format: Fireside Chat
Date and Time: Tuesday, November 12, 2:00 pm Eastern Time

Jefferies London Healthcare Conference (November 19 – 21, 2024)
Location: The Waldorf Hilton, London, UK
Format: Presentation
Date and Time: Wednesday, November 20, 12:30 pm Greenwich Mean Time

7th Annual Evercore HealthCONx Conference (December 3 – 5, 2024)
Location: Loews Coral Gables Hotel, Coral Gables, FL
Format: Fireside Chat
Date and Time: Wednesday, December 4, 11:15 am Eastern Time

A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 90 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Erasca, Inc.


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment